Literature DB >> 21874112

Triple-negative and basal-like breast cancer: implications for oncologists.

J Lachapelle1, W D Foulkes.   

Abstract

Entities:  

Year:  2011        PMID： 21874112      PMCID： PMC3149541          DOI： 10.3747/co.v18i4.824

Source DB:  PubMed          Journal:  Curr Oncol        ISSN： 1198-0052            Impact factor:   3.677


× No keyword cloud information.
  22 in total

1.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.

Authors:  T Sørlie; C M Perou; R Tibshirani; T Aas; S Geisler; H Johnsen; T Hastie; M B Eisen; M van de Rijn; S S Jeffrey; T Thorsen; H Quist; J C Matese; P O Brown; D Botstein; P E Lønning; A L Børresen-Dale
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

2.  Activation of multiple proto-oncogenic tyrosine kinases in breast cancer via loss of the PTPN12 phosphatase.

Authors:  Tingting Sun; Nicola Aceto; Kristen L Meerbrey; Jessica D Kessler; Chunshui Zhou; Ilenia Migliaccio; Don X Nguyen; Natalya N Pavlova; Maria Botero; Jian Huang; Ronald J Bernardi; Earlene Schmitt; Guang Hu; Mamie Z Li; Noah Dephoure; Steven P Gygi; Mitchell Rao; Chad J Creighton; Susan G Hilsenbeck; Chad A Shaw; Donna Muzny; Richard A Gibbs; David A Wheeler; C Kent Osborne; Rachel Schiff; Mohamed Bentires-Alj; Stephen J Elledge; Thomas F Westbrook
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

3.  A single-centre chart review exploring the adjusted association between breast cancer phenotype and prognosis.

Authors:  C Hamm; M El-Masri; G Poliquin; V Poliquin; J Mathews; S Kanjeekal; Y Alam; S Kulkarni; T Elfiki
Journal:  Curr Oncol       Date:  2011-08       Impact factor: 3.677

4.  Pathologic complete response rates in young women with BRCA1-positive breast cancers after neoadjuvant chemotherapy.

Authors:  Tomasz Byrski; Jacek Gronwald; Tomasz Huzarski; Ewa Grzybowska; Magdalena Budryk; Malgorzata Stawicka; Tomasz Mierzwa; Marek Szwiec; Rafal Wisniowski; Monika Siolek; Rebecca Dent; Jan Lubinski; Steven Narod
Journal:  J Clin Oncol       Date:  2009-12-14       Impact factor: 44.544

Review 5.  Neoadjuvant chemotherapy for "triple negative" breast cancer: a review of current practice and future outlook.

Authors:  Zeina Nahleh
Journal:  Med Oncol       Date:  2009-06-10       Impact factor: 3.064

Review 6.  Basal-like breast carcinoma: from expression profiling to routine practice.

Authors:  Emad Rakha; Jorge S Reis-Filho
Journal:  Arch Pathol Lab Med       Date:  2009-06       Impact factor: 5.534

Review 7.  Molecular classification of breast carcinomas by immunohistochemical analysis: are we ready?

Authors:  Ping Tang; Kristin A Skinner; David G Hicks
Journal:  Diagn Mol Pathol       Date:  2009-09

8.  Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer.

Authors:  Daniel P Silver; Andrea L Richardson; Aron C Eklund; Zhigang C Wang; Zoltan Szallasi; Qiyuan Li; Nicolai Juul; Chee-Onn Leong; Diana Calogrias; Ayodele Buraimoh; Aquila Fatima; Rebecca S Gelman; Paula D Ryan; Nadine M Tung; Arcangela De Nicolo; Shridar Ganesan; Alexander Miron; Christian Colin; Dennis C Sgroi; Leif W Ellisen; Eric P Winer; Judy E Garber
Journal:  J Clin Oncol       Date:  2010-01-25       Impact factor: 44.544

9.  Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial.

Authors:  Paul Ellis; Peter Barrett-Lee; Lindsay Johnson; David Cameron; Andrew Wardley; Susan O'Reilly; Mark Verrill; Ian Smith; John Yarnold; Robert Coleman; Helena Earl; Peter Canney; Chris Twelves; Christopher Poole; David Bloomfield; Penelope Hopwood; Stephen Johnston; Mitchell Dowsett; John M S Bartlett; Ian Ellis; Clare Peckitt; Emma Hall; Judith M Bliss
Journal:  Lancet       Date:  2009-05-16       Impact factor: 79.321

10.  Tumor size is an unreliable predictor of prognosis in basal-like breast cancers and does not correlate closely with lymph node status.

Authors:  William D Foulkes; Matthew J Grainge; Emad A Rakha; Andrew R Green; Ian O Ellis
Journal:  Breast Cancer Res Treat       Date:  2008-07-04       Impact factor: 4.872
View more
  13 in total

1.  Cinical Significance of Androgen Receptor, CK-5/6, KI-67 and Molecular Subtypes in Breast Cancer.

Authors:  Münire Kayahan; Ufuk Oğuz İdiz; Zuhal Gucin; Fazilet Erözgen; Naim Memmi; Mahmut Müslümanoğlu
Journal:  J Breast Health       Date:  2014-10-01

2.  Next Generation Sequencing Reveals High Prevalence of BRCA1 and BRCA2 Variants of Unknown Significance in Early-Onset Breast Cancer in African American Women.

Authors:  Luisel Ricks-Santi; J Tyson McDonald; Bert Gold; Michael Dean; Nicole Thompson; Muneer Abbas; Bradford Wilson; Yasmine Kanaan; Tammey J Naab; Georgia Dunston
Journal:  Ethn Dis       Date:  2017-04-20       Impact factor: 1.847

3.  BRCA1 polymorphisms and breast cancer epidemiology in the Western New York exposures and breast cancer (WEB) study.

Authors:  Luisel J Ricks-Santi; Jing Nie; Catalin Marian; Heather M Ochs-Balcom; Maurizio Trevisan; Stephen B Edge; Yasmine Kanaan; Jo L Freudenheim; Peter G Shields
Journal:  Genet Epidemiol       Date:  2013-05-14       Impact factor: 2.135

4.  Expression of the androgen receptor and its correlation with molecular subtypes in 980 chinese breast cancer patients.

Authors:  Ji-Ping Qi; You-Lin Yang; Hong Zhu; Jianmin Wang; Ying Jia; Na Liu; Yue-Jia Song; Li-Kun Zan; Xu Zhang; Min Zhou; Yun-He Gu; Tao Liu; David G Hicks; Ping Tang
Journal:  Breast Cancer (Auckl)       Date:  2011-12-06

Review 5.  Characterisation of the triple negative breast cancer phenotype associated with the development of central nervous system metastases.

Authors:  Katerin Rojas Laimito; Angelo Gámez-Pozo; Juan Sepúlveda; Luis Manso; Rocío López-Vacas; Tomás Pascual; Juan A Fresno Vara; Eva Ciruelos
Journal:  Ecancermedicalscience       Date:  2016-04-11

6.  Triple-negative breast cancer is associated with EGFR, CK5/6 and c-KIT expression in Malaysian women.

Authors:  Shant Kishen Kanapathy Pillai; Annie Tay; Suseela Nair; Chee-Onn Leong
Journal:  BMC Clin Pathol       Date:  2012-09-26

7.  SPOCK1 Is a Novel Transforming Growth Factor-β-Induced Myoepithelial Marker That Enhances Invasion and Correlates with Poor Prognosis in Breast Cancer.

Authors:  Li-Ching Fan; Yung-Ming Jeng; Yueh-Tong Lu; Huang-Chun Lien
Journal:  PLoS One       Date:  2016-09-14       Impact factor: 3.240

8.  mir-101-3p is a key regulator of tumor metabolism in triple negative breast cancer targeting AMPK.

Authors:  Peng Liu; Feng Ye; Xinhua Xie; Xing Li; Hailin Tang; Shuaijie Li; Xiaojia Huang; Cailu Song; Weidong Wei; Xiaoming Xie
Journal:  Oncotarget       Date:  2016-06-07

Review 9.  The Epigenetics of Triple-Negative and Basal-Like Breast Cancer: Current Knowledge.

Authors:  Daiana Cosmina Temian; Laura Ancuta Pop; Alexandra Iulia Irimie; Ioana Berindan-Neagoe
Journal:  J Breast Cancer       Date:  2018-09-20       Impact factor: 3.588

10.  Proteomics characterisation of central nervous system metastasis biomarkers in triple negative breast cancer.

Authors:  Katerin Rojas L; Lucía Trilla-Fuertes; Angelo Gámez-Pozo; Cristina Chiva; Juan Sepúlveda; Luis Manso; Guillermo Prado-Vázquez; Andrea Zapater-Moros; Rocío López-Vacas; María Ferrer-Gómez; César Mendiola; Enrique Espinosa; Eduard Sabidó; Eva Ciruelos; Juan Ángel Fresno Vara
Journal:  Ecancermedicalscience       Date:  2019-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.